Monocytes Stimulated with Group B Streptococci or Interferons Release Tumour Necrosis Factor‐Related Apoptosis‐Inducing Ligand
- 5 July 2004
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 60 (1-2), 74-81
- https://doi.org/10.1111/j.0300-9475.2004.01448.x
Abstract
Tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a cytotoxic member of the TNF family. Some reports have shown that TRAIL is released from cells in a soluble form. In this work, we have investigated the mechanism of release of TRAIL from monocytes. First, we show that whole gram-positive, gram-negative and mycoplasmal bacteria as well as lipopolysaccharide (LPS), interferon-alpha (IFN-alpha), -beta and -gamma all induced upregulation of TRAIL on the surface of human monocytes. Next, we show that IFN-alpha, -beta and -gamma all induced a dose-dependent release of TRAIL, giving significant amounts of soluble TRAIL after 2 days. Of the bacteria, only the Group B streptococcus COH-1 (GBS) induced release of TRAIL and concomittantly induced IFN-alpha. Monocytes stimulated with GBS or IFN-alpha also showed extensive cell death. When monocyte apoptosis was prevented by interleukin-1, GM-CSF, LPS or the caspase inhibitor zVADfmk, the IFN-alpha-induced release of TRAIL was reduced, whereas agents inducing necrosis caused increased release of TRAIL. LPS also prevented release of TRAIL from GBS-stimulated monocytes. The release of TRAIL from IFN-alpha-stimulated monocytes was reduced by inhibitors of both cysteine and metalloproteases. We conclude that bacteria and IFN induce upregulation of membrane TRAIL and that release of TRAIL is associated with cell death.Keywords
This publication has 36 references indexed in Scilit:
- Tumor Necrosis Factor (TNF) and Phorbol Ester Induce TNF-related Apoptosis-inducing Ligand (TRAIL) under Critical Involvement of NF-κB Essential Modulator (NEMO)/IKKγPublished by Elsevier ,2001
- Staphylococcus aureusandSalmonella entericaSerovar Dublin Induce Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Expression by Normal Mouse and Human OsteoblastsInfection and Immunity, 2001
- ROLE OF TYPE I INTERFERONS DURING MACROPHAGE ACTIVATION BY LIPOPOLYSACCHARIDECytokine, 2000
- Lipopolysaccharide Induces Expression of APO2 Ligand/TRAIL in Human Monocytes and MacrophagesScandinavian Journal of Immunology, 2000
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- Monocyte-mediated Tumoricidal Activity via the Tumor Necrosis Factor–related Cytokine, TRAILThe Journal of Experimental Medicine, 1999
- Death Receptors: Signaling and ModulationScience, 1998
- Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine FamilyJournal of Biological Chemistry, 1996
- Metalloproteinase-mediated release of human Fas ligand.The Journal of Experimental Medicine, 1995
- Identification and characterization of a new member of the TNF family that induces apoptosisImmunity, 1995